Código QR (código de barras bidimensional)

Efficacy and safety of biosimilar trastuzumab (HLX02) in patients with HER2-positive advanced breast cancer: a retrospective real-world analysis

BackgroundHLX02 is the first China-manufactured trastuzumab biosimilar. Few data are currently available about HLX02 in clinical practice. This study was designed to evaluate the real-world safety and efficacy of HLX02 in patients with HER2-positive metastatic breast cancer (MBC), as well as assesse...

ver descrição completa

Na minha lista:
Principais autores: Xuan Ye, Linlin Wang, Wensheng Liu, Mengmeng Wang, Zihan Guo, Han Shan, Qing Zhai, Qiong Du
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2025-08-01
coleção:Frontiers in Oncology
Assuntos:
HLX02
trastuzumab
biosimilar
metastatic breast cancer
real-world study
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2025.1622854/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados